Adocia SA (EPA:ADOC)
France · Delayed Price · Currency is EUR 5.04
+0.07 (1.31%)
May 14, 2026, 5:35 PM CET
Adocia Revenue
In the year 2025, Adocia had annual revenue of 3.85M EUR, down -68.26%. Adocia had revenue of 1.65M in the half year ending December 31, 2025, a decrease of -23.23%.
Revenue
3.85M
Revenue Growth
-68.26%
P/S Ratio
25.31
Revenue / Employee
49.97K
Employees
80
Market Cap
97.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.85M | -8.28M | -68.26% |
| Dec 31, 2024 | 12.12M | 6.08M | 100.43% |
| Dec 31, 2023 | 6.05M | -11.31M | -65.16% |
| Dec 31, 2022 | 17.36M | 11.31M | 186.72% |
| Dec 31, 2021 | 6.06M | -778.00K | -11.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cellectis | 65.14M |
| Nicox | 18.95M |
| Fermentalg | 13.38M |
| Innate Pharma | 9.01M |
| Transgene | 7.21M |
| Sensorion | 5.81M |
| MaaT Pharma | 4.52M |
| ABIONYX Pharma | 4.10M |